Compare RVLV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVLV | CRNX |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 4.1B |
| IPO Year | 2019 | 2018 |
| Metric | RVLV | CRNX |
|---|---|---|
| Price | $28.33 | $50.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $26.42 | ★ $71.00 |
| AVG Volume (30 Days) | 958.4K | ★ 1.1M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.78 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $1,195,039,000.00 | $1,535,000.00 |
| Revenue This Year | $8.95 | $425.31 |
| Revenue Next Year | $6.42 | $943.50 |
| P/E Ratio | $36.69 | ★ N/A |
| Revenue Growth | 9.24 | ★ 47.74 |
| 52 Week Low | $16.80 | $24.10 |
| 52 Week High | $39.58 | $60.25 |
| Indicator | RVLV | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 70.51 | 72.28 |
| Support Level | $25.48 | $46.49 |
| Resistance Level | $29.32 | $49.29 |
| Average True Range (ATR) | 1.21 | 1.96 |
| MACD | 0.40 | 0.41 |
| Stochastic Oscillator | 84.41 | 94.31 |
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.